YOU (YOU)

$6.6B
Market Cap
43.5
P/E Ratio
1.10
Beta
1.26%
Dividend Yield
Piotroski 6/9Altman Z 4.9 SafeBeneish M -1.29 Flag (> −2.22)ROIC−WACC +15.6%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 4.9. Beneish M-Score of -1.29 exceeds the -2.22 academic threshold — earnings quality may warrant further review.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The company exhibits robust fundamental economics, characterized by a high ROIC of 27.1% and an aggressive DuPont decomposition where equity multipliers drive returns alongside healthy asset turnover and net margins. This leverage-heavy structure is reinforced by strong profitability metrics, including a gross margin of 64.4% and revenue growth accelerating at 16.9% year-over-year. Quality indicators further support this profile; the Piotroski F-Score of 6/9 suggests solid financial health with positive operating trends, while the Beneish M-Score of -1.29 indicates a low probability of earnings manipulation. However, the valuation presents a significant divergence from these operational strengths, as the current P/E ratio of 43.5x implies substantial growth expectations that may not be fully reflected in near-term cash flows compared to historical or sector benchmarks.

A discounted cash flow analysis places fair value at $100 per share, suggesting the market is pricing in a specific trajectory of implied future growth that must materialize for current levels to remain justified. The disconnect between high-quality fundamentals and elevated multiples creates a scenario where any miss on execution could trigger a re-rating toward intrinsic value. Compounding this valuation pressure, insider activity over the last 90 days reveals net selling totaling $53.87 million, which often signals management's lack of conviction at current price levels or portfolio rebalancing rather than organic growth optimism.

The risk-reward profile is defined by a tension between superior operational efficiency and aggressive pricing relative to peers. While the high ROIC and clean earnings quality provide a defensive moat against value traps, the combination of premium valuation and significant insider outflows introduces downside volatility if consensus estimates fail to materialize. Investors must weigh whether the current multiple adequately compensates for the leverage inherent in the equity multiplier or if it leaves insufficient margin of safety given the recent capital flight from insiders.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →9.5%11.5%13.5%
2%$118$91$73
3%$133$100$79
4%$154$110$85

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=11.5%, terminal growth 3%. Fair value $100 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
4.9
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-1.29
Beneish M-Score
Above threshold — earnings quality may warrant further review per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

64.4%
Gross Margin
12.1%
Net Margin
27.1%
ROIC
11.5%
WACC
ROIC − WACC Spread: +15.6%— Positive value creation spread.
+16.9%
Revenue Growth (YoY)
-35.7%
Earnings Growth (YoY)
343.1M
Free Cash Flow
27%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

12.1%
Net Profit Margin
NI ÷ Revenue
×
0.69x
Asset Turnover
Revenue ÷ Assets
×
6.38x
Equity Multiplier
Assets ÷ Equity
=
53.4%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

5.38x
Debt / Equity
1.01x
Current Ratio
0.1x
Net Debt / EBITDA
5.21%
FCF Yield
221.1M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$54M
Net Selling
0
Buy Transactions
10
Sale Transactions
2026-03-13SEIDMAN BECKER CARYNSold 2/8 qtrsOther200,000 shares
2026-03-12SEIDMAN BECKER CARYNSold 2/8 qtrsGrant200,000 shares
2026-03-12ALCLEAR INVESTMENTS, L.L.C.Sold 2/8 qtrsGrant200,000 shares
2026-03-05SEIDMAN BECKER CARYNSold 2/8 qtrsGrant174,324 shares
2026-03-05ALCLEAR INVESTMENTS, L.L.C.Sold 2/8 qtrsGrant174,324 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $0.30
Act: $0.34
+15.6%
Q3
✓ Beat
Est: $0.34
Act: $0.36
+5.9%
Q2
✓ Beat
Est: $0.33
Act: $0.37
+12.7%
Q1
✓ Beat
Est: $0.43
Act: $0.46
+6.7%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

17.4
Forward P/E
PEG Ratio
26.98
Price/Book
2M
Avg Volume
$56.51
52W High
$23.00
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$305M
Tracked Passive Exposure
8
ETFs Holding YOU
0.08%
Avg Weight in ETFs
$381B
Total ETF AUM

When investors buy or sell ETFs like XSW or SLYG, the fund manager is mechanically forced to buy or sell YOU shares regardless of YOU's individual fundamentals. We estimate $305M of passive capital is structurally linked to YOU through 8 tracked ETFs. Passive flows have a limited but growing influence on YOU's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in YOU to visualize passive redemption contagion across ETFs and collateral stocks.

YOU Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
YOUEpicenterVGTETFVYMETFVXFETFBELow RiskSANMMed RiskVIAVHigh RiskSMTCUnknownFORMLow Risk
YOU Price Drop (%)0

If YOU (YOU) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Bloom Energy Corp. Class A (BE) as the most exposed collateral stock, sharing 2 ETFs with YOU. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 10 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

YOU Ownership Dynamics

Ticker
YOU

Float lock-up computed from 10 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

YOU Capital Efficiency

How efficiently does YOU convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$343M
EBITDA
$221M
FCF Conversion
155%
Reinvestment Rate
-55%
155% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
27.1%
ROIC − WACC Spread
15.6%

YOU converts 155% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 15.6% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1414$55.54$777.56
2026-05-1339,617$57.64$2.3M
2026-04-2123$56.83$1,307.09
2026-03-261,892$54.48$103,076.16
2026-03-25846$53.53$45,286.38
2026-03-23328$48.12$15,783.36
2026-03-1670$44.63$3,124.1
2026-03-132,160$44.81$96,789.6
2026-03-10621$46.23$28,708.83
2026-02-273,735$47.12$175,993.2
2026-02-101,720$33.02$56,794.4
2026-02-0697$32.59$3,161.23
2026-01-2982$33.48$2,745.36
2026-01-021,829$35.08$64,161.32
2025-12-22442$36.98$16,345.16
2025-12-1158$35.77$2,074.66
2025-12-02649$34.53$22,409.97
2025-11-26854$35.73$30,513.42
2025-11-245,883$35.85$210,905.55
2025-11-14100$38.04$3,804
2025-11-128,493$37.25$316,364.25
2025-11-041,822$30.86$56,226.92
2025-11-03338$30.47$10,298.86
2025-10-27178$31.30$5,571.4
2025-10-21388$31.72$12,307.36
2025-10-16390$31.59$12,320.1
2025-10-07170$31.03$5,275.1

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare YOU to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.